Medical Developments International Limited
MDDVF
$0.37
$0.0721.99%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.71% | 5.38% | 2.60% | 0.68% | 32.51% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 8.71% | 5.38% | 2.60% | 0.68% | 32.51% |
| Cost of Revenue | 9.42% | 6.08% | -9.86% | -11.55% | 29.10% |
| Gross Profit | 8.45% | 5.13% | 6.99% | 4.98% | 33.77% |
| SG&A Expenses | 8.66% | 5.34% | -1.35% | -3.20% | -39.77% |
| Depreciation & Amortization | -13.84% | -16.47% | -16.43% | -17.99% | 4.62% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.04% | 3.77% | -4.69% | -6.47% | -26.78% |
| Operating Income | 107.49% | 101.26% | 60.45% | 61.19% | 102.82% |
| Income Before Tax | -172.80% | -170.53% | 99.28% | 99.29% | 102.48% |
| Income Tax Expenses | -123.81% | -122.73% | -99.40% | -99.41% | 100.70% |
| Earnings from Continuing Operations | -174.95% | -172.59% | 99.32% | 99.33% | 102.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -174.95% | -172.59% | 99.32% | 99.33% | 102.78% |
| EBIT | 107.49% | 101.26% | 60.45% | 61.19% | 102.82% |
| EBITDA | 7.05% | 3.76% | 91.40% | 103.57% | 118.85% |
| EPS Basic | -177.78% | -177.78% | 99.48% | 99.48% | 102.18% |
| Normalized Basic EPS | -166.67% | -166.67% | 96.67% | 96.67% | 101.99% |
| EPS Diluted | -177.78% | -177.78% | 99.48% | 99.48% | 102.18% |
| Normalized Diluted EPS | -166.67% | -166.67% | 96.67% | 96.67% | 101.99% |
| Average Basic Shares Outstanding | 4.93% | 4.93% | 30.48% | 30.48% | 24.41% |
| Average Diluted Shares Outstanding | 0.07% | 0.07% | 30.48% | 30.48% | 30.44% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |